Global Cytotoxic Drug Delivery - What are the key segments and addressable markets that comprise the market for cytotoxic drug delivery - kcentv.com - KCEN HD - Waco, Temple, and Killeen

Global Cytotoxic Drug Delivery - What are the key segments and addressable markets that comprise the market for cytotoxic drug delivery

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, May 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/xdvjj5/cytotoxic_drug) has announced the addition of the "Cytotoxic Drug Delivery" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that - in spite of promising new drugs based on therapeutic antibodies - continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers.

Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues.

Highlights

  • What are the key segments and addressable markets that comprise the market for cytotoxic drug delivery?
  • What are the major therapeutic demand drivers for cytotoxic drug therapeutics?
  • What are the design factors and technologies that are being used in commercial and development-stage closed drug transfer systems?
  • What is the market share and product position in the market and what will it look like in 2018?
  • Who are the companies behind the current generation of cytotoxic transfer solutions and what are their business models?
  • What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging closed drug transfer systems?
  • What is the impact of economic, technology, and regulatory factors?

Key Topics Covered:

Executive Summary

The Executive Summary

Therapeutic Trends and Issues
The Administration of injectable/Infusable Antineoplastics
Drug Packaging and Administration Technology
Closed Drug Transfer - Driving Forces
Competitive Landscape
Risk Factors

Cytotoxic Drug Transfer Systems - The Current Generation

Key System Design Elements
Human Engineering/Ergonomics
Material Selection Issues
Drug Reconstitution and Dilution
Oncology Therapeutics Medication Safety
Oncology Drug Administration and Dosing
Drug-Specific Dosing Modification and Individualized Dosing

Closed Drug Transfer Commercial Device Assessments & Market Data

FDA Approved Products
Commercialized Non-FDA Approved Products
Closed Drug Transfer Component Suppliers

Market Factors

Regulatory Issues
Caregiver Compliance
Level of Complexity and Ease of Use
Healthcare Economics
Business Models and Strategies

Market Assessments and Forecasts

  • North America
  • Europe
  • Asia
  • Other Geographic Markets

Company Profiles

For more information visit http://www.researchandmarkets.com/research/xdvjj5/cytotoxic_drug

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KCEN. All Rights Reserved. Users of this site agree to the Terms of Service, Privacy Notice/Your California Privacy Rights, and Ad Choices.